13-20414206-TACACACACACAC-TACAC
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 0P and 0B.
The NM_015974.3(CRYL1):c.634-827_634-820delGTGTGTGT variant causes a intron change involving the alteration of a non-conserved nucleotide. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.00023 ( 0 hom., cov: 0)
Consequence
CRYL1
NM_015974.3 intron
NM_015974.3 intron
Scores
Not classified
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.523
Publications
0 publications found
Genes affected
CRYL1 (HGNC:18246): (crystallin lambda 1) The uronate cycle functions as an alternative glucose metabolic pathway, accounting for about 5% of daily glucose catabolism. The product of this gene catalyzes the dehydrogenation of L-gulonate into dehydro-L-gulonate in the uronate cycle. The enzyme requires NAD(H) as a coenzyme, and is inhibited by inorganic phosphate. A similar gene in the rabbit is thought to serve a structural role in the lens of the eye. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_015974.3. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CRYL1 | TSL:1 MANE Select | c.634-827_634-820delGTGTGTGT | intron | N/A | ENSP00000298248.7 | Q9Y2S2-1 | |||
| CRYL1 | TSL:1 | c.568-827_568-820delGTGTGTGT | intron | N/A | ENSP00000372262.1 | Q9Y2S2-2 | |||
| CRYL1 | c.595-827_595-820delGTGTGTGT | intron | N/A | ENSP00000557682.1 |
Frequencies
GnomAD3 genomes AF: 0.000226 AC: 34AN: 150490Hom.: 0 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
34
AN:
150490
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.000226 AC: 34AN: 150608Hom.: 0 Cov.: 0 AF XY: 0.000381 AC XY: 28AN XY: 73502 show subpopulations
GnomAD4 genome
AF:
AC:
34
AN:
150608
Hom.:
Cov.:
0
AF XY:
AC XY:
28
AN XY:
73502
show subpopulations
African (AFR)
AF:
AC:
10
AN:
41020
American (AMR)
AF:
AC:
2
AN:
15150
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3458
East Asian (EAS)
AF:
AC:
5
AN:
5080
South Asian (SAS)
AF:
AC:
14
AN:
4736
European-Finnish (FIN)
AF:
AC:
0
AN:
10224
Middle Eastern (MID)
AF:
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
AC:
3
AN:
67668
Other (OTH)
AF:
AC:
0
AN:
2074
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.